GPCR

Structure Therapeutics Inc.

6 transactions on file, per SEC Form 4 filings.

Lin Xichen

CHIEF SCIENTIFIC OFFICER · 2026-09-01

Option exercise

$6K

Lin Xichen

CHIEF SCIENTIFIC OFFICER · 2026-09-01

C-Conversion

17,817 sh

Lin Xichen

CHIEF SCIENTIFIC OFFICER · 2026-09-01

C-Conversion

5,939 sh

Lin Xichen

CHIEF SCIENTIFIC OFFICER · 2026-09-01

Sold

1,300 sh

Lin Xichen

CHIEF SCIENTIFIC OFFICER · 2026-09-01

Sold

4,539 sh

Lin Xichen

CHIEF SCIENTIFIC OFFICER · 2026-09-01

Sold

100 sh

Each row links to the underlying SEC filing. Sells are shown for transparency, not as a signal — see the insider trading article for why.

Is GPCR actually a buy?

Following an insider into a stock isn't a strategy on its own. Run your own margin-of-safety analysis, free.